Silodosin Capsule
Product Images NDC 82619-113

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Silodosin (NDC 82619-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Creekwood Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (0fdaf6c9 C861 4894 B4a9 2f6a281998c1 01)

Chemical structure diagram of silodosin, the active ingredient in SILODOSIN capsules. The diagram depicts the molecular framework with elements including oxygen, nitrogen, and fluorine atoms, and distinct ring structures characteristic of silodosin.*

FDA Label Image

Image (0fdaf6c9 C861 4894 B4a9 2f6a281998c1 02)

A line graph showing silodosin concentration (ng/mL) over time (hours). The graph depicts a rise in silodosin levels peaking around 3 hours, followed by a gradual decline, with error bars indicating variability at each time point.*

FDA Label Image

Image (0fdaf6c9 C861 4894 B4a9 2f6a281998c1 03)

A line graph comparing change from baseline in IPSS total score over days between placebo and Silodosin capsules 8 mg. The y-axis shows change scores, and the x-axis shows days from baseline to 84/LOCF. Silodosin shows greater reduction in score compared to placebo throughout the study period.*

FDA Label Image

Image (0fdaf6c9 C861 4894 B4a9 2f6a281998c1 04)

A line graph showing change from baseline in IPSS total score over time, comparing Silodosin 8 mg capsules with placebo. The x-axis represents days, ranging from baseline to day 84, and the y-axis shows the change in score, with Silodosin demonstrating a greater decrease than placebo.*

FDA Label Image

Image (0fdaf6c9 C861 4894 B4a9 2f6a281998c1 05)

A line graph comparing the change from baseline in Qmax (mL/sec) over multiple days between placebo and Silodosin Capsules 8 mg. The graph shows higher Qmax improvement for Silodosin 8 mg than placebo, with statistically significant differences noted (p<0.05).*

FDA Label Image

Image (0fdaf6c9 C861 4894 B4a9 2f6a281998c1 06)

A line graph showing change from baseline in Qmax (mL/sec) over time in days for Silodosin Capsules 8 mg compared to placebo. Data points are plotted at baseline, days 1, 7, 14, 28, and 84 with Silodosin showing a higher increase in Qmax than placebo throughout the timepoints. Statistical significance is indicated at certain points.*

FDA Label Image

Image (0fdaf6c9 C861 4894 B4a9 2f6a281998c1 07)

Silodosin 4 mg capsules packaging label showing 30 capsules per bottle. Distributed by Creekwood Pharmaceuticals LLC, with manufacturing by V-Ensure Pharma Technologies Pvt. Ltd. The label includes storage instructions, child-resistant packaging note, barcode, and dosage information indicating one capsule daily with a meal.*

FDA Label Image

Image (0fdaf6c9 C861 4894 B4a9 2f6a281998c1 08)

Silodosin 8 mg capsules packaging label from Creekwood Pharmaceuticals LLC. The label indicates 30 capsules per container, prescription only, with storage instructions and child-resistant packaging notice. Manufactured by V-Ensure Pharma Technologies Pvt. Ltd. in India, it includes dosage information and a barcode.*

FDA Label Image

Image (0fdaf6c9 C861 4894 B4a9 2f6a281998c1 09)

Silodosin Capsules 8 mg, oral capsules supplied in a 90-count package. The label shows the NDC 82619-114-02 and states the product is Rx only. Distributed by Creekwood Pharmaceuticals LLC, Parsippany, NJ, and manufactured by V-Ensure Pharma Technologies Pvt. Ltd., India. The label includes storage, dosage, and child-resistance information along with a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.